Charles Schwab Investment Management Inc Evolus, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 418,576 shares of EOLS stock, worth $5.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

418,576

Previous 152,941 173.68%

Holding current value

$5.3 Million

Previous $1.66 Million 308.68%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.66 - $17.48 $2.83 Million - $4.64 Million	265,635 Added 173.68%	418,576 $6.78 Million
Q2 2024 Aug 12, 2024	BUY	$10.45 - $13.76 $441,564 - $581,428	42,255 Added 38.18%	152,941 $1.66 Million
Q1 2024 May 08, 2024	SELL	$9.99 - $14.91 $40,889 - $61,026	-4,093 Reduced 3.57%	110,686 $1.55 Million
Q4 2023 Feb 06, 2024	BUY	$7.6 - $10.53 $1,314 - $1,821	173 Added 0.15%	114,779 $1.21 Million
Q3 2023 Nov 08, 2023	BUY	$7.15 - $10.2 $19,061 - $27,193	2,666 Added 2.38%	114,606 $1.05 Million
Q2 2023 Aug 09, 2023	BUY	$7.23 - $10.52 $101,248 - $147,322	14,004 Added 14.3%	111,940 $813,000
Q1 2023 May 11, 2023	BUY	$7.81 - $11.05 $40,385 - $57,139	5,171 Added 5.57%	97,936 $828,000
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.95 $11,794 - $16,190	1,809 Added 1.99%	92,765 $696,000
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $2,747 - $4,856	-354 Reduced 0.39%	90,956 $733,000
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $282,460 - $385,273	-27,638 Reduced 23.24%	91,310 $1.06 Million
Q1 2022 May 13, 2022	SELL	$5.22 - $11.78 $271,528 - $612,760	-52,017 Reduced 30.43%	118,948 $1.34 Million
Q3 2021 Nov 16, 2021	BUY	$7.36 - $13.67 $657,328 - $1.22 Million	89,311 Added 109.38%	170,965 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $231,937 - $384,542	27,546 Added 50.91%	81,654 $1.03 Million
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $10,707 - $55,242	-3,346 Reduced 5.82%	54,108 $703,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $26,986 - $47,169	7,645 Added 15.35%	57,454 $305,000
Q4 2019 Feb 07, 2020	BUY	$11.58 - $17.37 $174,024 - $261,036	15,028 Added 43.21%	49,809 $607,000
Q3 2019 Nov 08, 2019	BUY	$13.91 - $19.87 $119,459 - $170,643	8,588 Added 32.79%	34,781 $544,000
Q2 2019 Aug 09, 2019	BUY	$13.19 - $28.36 $55,595 - $119,537	4,215 Added 19.18%	26,193 $383,000
Q1 2019 May 14, 2019	BUY	$12.43 - $28.91 $20,534 - $47,759	1,652 Added 8.13%	21,978 $497,000
Q4 2018 Feb 14, 2019	BUY	$10.57 - $19.29 $4,397 - $8,024	416 Added 2.09%	20,326 $242,000
Q3 2018 Nov 13, 2018	BUY	$17.31 - $29.82 $185,390 - $319,372	10,710 Added 116.41%	19,910 $371,000
Q2 2018 Aug 08, 2018	BUY	$6.85 - $38.49 $63,020 - $354,108	9,200 New	9,200 $258,000

Others Institutions Holding EOLS

# of Institutions

169

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $711M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Evolus, Inc. Transaction History